ÖZKAN, Semra; GEZER, Deniz. The impact of dapagliflozin on FIB-4 index over 2 years in patients with type 2 diabetes mellitus. The European Research Journal, [S. l.], v. 11, n. 4, p. 676–682, 2025. DOI: 10.18621/eurj.1631079. Disponível em: https://eurj.org.tr/article/view/1061. Acesso em: 5 apr. 2026.